A large study analyzing the DNA of children with cerebral palsy has found a high prevalence of genomic variation that likely contributes to the risk of […]

Multiple sclerosis (MS) has three distinct subtypes based on immune markers in patient’s blood, each with slightly different disease trajectories and responses to therapy, a new […]

The prevalence of dementia among homeless people is almost twice as high as that in housed populations in Ontario, Canada, according to the results of a […]

Amylyx Pharmaceuticals has announced plans to take sodium phenylbutyrate–taurursodiol (Relyvrio and Albrioza), its drugs for amyotrophic lateral sclerosis (ALS), off the market in the United States […]

Nontraditional risk factors such as migraine and autoimmune diseases have a significantly greater effect on stroke risk in young adults than traditional risk factors such as […]

Cognitive assessments administered via a smartphone app are a reliable and valid way to detect frontotemporal dementia (FTD) in high-risk individuals, new research showed. Cognitive tests […]

Early treatment of pediatric-onset relapsing-remitting multiple sclerosis (MS) with high-efficacy therapy (HET) is associated with substantially slower disability progression than treatment with low-efficacy therapies or no […]

The Epstein-Barr virus (EBV) is our constant companion, infecting an estimated 90%-95% of adults. Many of us are first infected as children, when the germ may […]

TOPLINE: Over time, exercising at least twice a week is associated with significantly fewer insomnia symptoms and better sleep duration, new research shows. METHODOLOGY: The study […]